Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

西乐葆 - NMPA Drug Approval Details

Approvals/NMPA/Celecoxib Capsules

Approved

化学药品

Celecoxib Capsules

Unknown🇨🇳 National Medical Products Administration

Approval Date: Feb 14, 2023
Approval ID: 1xpZro55RIK
Company: Unknown
Type: 化学药品

Approval Details

Approval Id: 1xpZro55RIK
Approval Number: 国药准字HJ20140106
Generic Name: 塞来昔布胶囊
Generic Name En: Celecoxib Capsules
Trade Name: 西乐葆
Drug Type: 化学药品
Dosage Form: 胶囊剂
Strength: 0.2g
Reg Date: 2023-02-14
Expired Date: 2028-02-13
Production Company Name: Viatris Pharmaceuticals LLC
Company Detail Path: /organization/upjohn-us-2-llc
Production Company Detail Path: /organization/viatris-pharmaceuticals-llc

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Feb 14, 2023

Approval ID

1xpZro55RIK

Type

化学药品

Back to NMPA Approvals